Share Prices & Company Research

Market News

04 Jul 2018 | 14:57

C4X Discovery appoints Eva-Lotta Allan as chairman

Drug discovery company C4X Discovery Holdings said it had appointed Eva-Lotta Allan as its new chairman.

Interim chairman Sam Williams would stand down to focus on his other business interests.

The company said it had also appointed Natalie Walter as a non-executive director.

Allan was most recently chief business officer at Immunocore, where she held full responsibility for all aspects of business development and played an instrumental role in the $320 million fundraising in 2015, C4X said.

At 2:57pm: (LON:C4XD) C4x Discovery Holdings Plc share price was +1.5p at 96.5p

Story provided by
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.